Latest Walgreen Company (WAG) Headlines
Rite Aid Gains on Comps, Hits New High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 14, 10:00AM CDT
Shares of Rite Aid have been gaining momentum since the company released its comparable store sales (comps) results on Mar 6, 2014.
Quarterly Dividends, Store Sales Report, New Health Program, Company Recognition, Stock Trade Movement - Analyst Notes on CVS Caremark, Walgreens, Rite Aid, GNC, and Cardinal Health
PR Newswire - Fri Mar 14, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding CVS Caremark Corporation (NYSE: CVS), Walgreen Company (NYSE: WAG), Rite Aid Corporation (NYSE: RAD), GNC Holdings Inc (NYSE: GNC), and Cardinal Health Inc (NYSE: CAH). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Retail Industry Stock Outlook - March 2014 - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 4:16AM CDT
Retail Industry Stock Outlook - March 2014 - Industry Outlook
Retail Industry Stock Outlook - March 2014 - Zacks Analyst Interviews
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 4:16AM CDT
Retail Industry Stock Outlook - March 2014 - Zacks Analyst Interviews
Why Rite Aid, VeriFone Systems, and Diamond Foods Jumped Today
Dan Caplinger, The Motley Fool - Motley Fool - Wed Mar 12, 7:00PM CDT
On Wednesday, investors appeared to remain nervous for most of the day about the same issues that have plagued the market all week, including the ongoing tensions between Russia and Ukraine and signs of a further slowdown in the Chinese economy. By...
Why Has David Einhorn Been Selling Rite Aid?
Selena Maranjian, The Motley Fool - Motley Fool - Wed Mar 12, 3:45PM CDT
The latest 13F season is here, when many money managers issue required reports on their holdings. It can be worthwhile to pay attention, as you might get an investment idea or two by seeing what some major investors have been buying and selling. ...
Next Resistance Level for Walgreen (WAG) is $67.59
Comtex SmarTrend(R) - Wed Mar 12, 10:15AM CDT
Walgreen (NYSE:WAG) has opened bullishly above the pivot of $66.66 today and has reached the first level of resistance at $67.06. Analysts will be watching for a cross of the next upside pivot targets of $67.59 and $68.52.
Is Rite Aid a Screaming Buy After Reporting Sales Figures?
Daniel Jones, The Motley Fool - Motley Fool - Wed Mar 12, 8:35AM CDT
Source: Wikimedia Commons After reporting sales for the month of February, Rite Aid , the world's third-largest publicly traded drugstore chain, saw its shares fall more than 1%. Although the company's performance for the month wasn't bad, it...
Will This Target Price Increase Help Walgreen (WAG) Today? (Update)
at The Street - Wed Mar 12, 8:24AM CDT
UBS increased its target price on Walgreen (WAG) to $90 and set a "buy" rating. The firm cited the company's specialty pharma tax inversion playbook to pharma services as the reason for the move.
Infinity Appoints Two Experienced Life Science Leaders to Its Board of Directors
Business Wire - Tue Mar 11, 3:07PM CDT
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that it has appointed Jose Baselga M.D., Ph.D. and Jeff Berkowitz as independent members of its board of directors. Dr. Baselga, physician-in-chief at Memorial Sloan Kettering Cancer Center, is an accomplished clinician and a thought leader in the PI3K field. Mr. Berkowitz, as the President of Walgreens Boots Alliance Development, GmbH (WAG) in Europe, has a wealth of experience in pharmaceuticals, pharmacy, distribution and market access, pricing and reimbursement.
Is Drugstore Titan CVS Caremark Still a Good Bet After Taking a Hard Stance Against Tobacco?
Robert Hanley, The Motley Fool - Motley Fool - Tue Mar 11, 1:17PM CDT
Drugstore giant CVS Caremark made waves in early February after disclosing its intention to forgo tobacco sales starting in October. While some pundits questioned CVS' motives, the policy makes sense for a company that generates the vast majority...
Is Rite Aid Corporation Getting Sick Again?
Adam Levine-Weinberg, The Motley Fool - Motley Fool - Tue Mar 11, 12:10PM CDT
In its recently ended 2014 fiscal year, Rite Aid Corporation made significant progress in returning to sustainable profitability. Through the first three quarters of the fiscal year, the company swung from a pre-tax loss of $69 million in FY13 to...
After Strong Sales Results, Is Walgreen a Strong Buy?
Daniel Jones, The Motley Fool - Motley Fool - Sun Mar 09, 9:00AM CDT
Source: Wikimedia Commons On March 5, shares of Walgreen ended the day down nearly 1% as the S&P 500 index stayed roughly even. The reason for the stock's drop was the sales release the business made public covering the month of February...
Rite Aid Feb Comps Rise - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 07, 1:20PM CST
Rite Aid's comparable store sales for the five weeks ended Mar 1, 2014 increased 1.5%
Harsh Winter Weather Cools February Retail Comps
at Investor's Business Daily - Thu Mar 06, 4:23PM CST
Retailers rang up sluggish sales gains in February as a harsh winter blast in many parts of America kept mall traffic weak and spending soft, though business rallied some in the second half of the month. February sales at stores open at least a year...
Feb Sales Up at Walgreen but Q2 Revs Miss Est. - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 1:50PM CST
Drug retailer Walgreens recently reported results for the month of Feb 2014.
Feb. Retail Comps Stay Chilled But Stage Late Rally
at Investor's Business Daily - Thu Mar 06, 12:06PM CST
Retailers posted soft February sales gains Thursday as frigid temperatures in many parts of the U.S. kept consumers out of the malls, but business picked up during the month's second half -- an encouraging sign given the harsh-weather head winds....
Rite Aid Corporation February Same-Store Sales Up 1.5%
Patrick Morris, The Motley Fool - Motley Fool - Thu Mar 06, 11:39AM CST
Rite Aid announced today that same-store sales last month overall were up 1.5%. Front-end same-store sales decreased 1.8% while pharmacy same-store sales rose 3.1%. Total sales rose from $2.46 billion in the comparable period last year to...
Walgreens and MyMedicalRecords Reach Settlement Agreement
Marketwire - Thu Mar 06, 7:15AM CST
MMRGlobal, Inc. (OTCQB: MMRF), through its wholly owned subsidiary MyMedicalRecords, Inc. (collectively, "MMR"), and Walgreen Co. (NYSE: WAG) (NASDAQ: WAG) ("Walgreens") announced today that they have entered into a Settlement and Licensing Agreement (the "Agreement") to resolve two patent infringement lawsuits brought by MMR. Pursuant to the terms of the Agreement, Walgreens purchased a Non-Exclusive License to the MMR family of patents. The settlement arises from litigation involving MMR's U.S. Patent No. 8,301,466 and U.S. Patent No. 8,498,883. MMR's patent portfolio also includes U.S. Patent Nos. 8,121,855; 8,117,045; 8,117,646; 8,301,466; 8,321,240; 8,352,287; 8,352,288; 8,498,883; 8,626,532 and 8,645,161 as well as numerous pending applications. Pursuant to the terms of the Agreement, Walgreens has also agreed to sell MMR's MyMedicalRecords Personal Health Record (the "MMR-PHR") on drugstore.com. The remaining terms of the Agreement are confidential.
Walgreen reports 5% rise in February sales
M2 - Thu Mar 06, 6:45AM CST
Drug store Walgreen (NYSE:WAG) stated on Wednesday that it recorded sales of USD6.05bin in February fiscal 2014.
Rite Aid Gains on Comps, Hits New High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 14, 10:00AM CDT
Shares of Rite Aid have been gaining momentum since the company released its comparable store sales (comps) results on Mar 6, 2014.
Quarterly Dividends, Store Sales Report, New Health Program, Company Recognition, Stock Trade Movement - Analyst Notes on CVS Caremark, Walgreens, Rite Aid, GNC, and Cardinal Health
PR Newswire - Fri Mar 14, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding CVS Caremark Corporation (NYSE: CVS), Walgreen Company (NYSE: WAG), Rite Aid Corporation (NYSE: RAD), GNC Holdings Inc (NYSE: GNC), and Cardinal Health Inc (NYSE: CAH). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Retail Industry Stock Outlook - March 2014 - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 4:16AM CDT
Retail Industry Stock Outlook - March 2014 - Industry Outlook
Retail Industry Stock Outlook - March 2014 - Zacks Analyst Interviews
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 4:16AM CDT
Retail Industry Stock Outlook - March 2014 - Zacks Analyst Interviews
Why Rite Aid, VeriFone Systems, and Diamond Foods Jumped Today
Dan Caplinger, The Motley Fool - Motley Fool - Wed Mar 12, 7:00PM CDT
On Wednesday, investors appeared to remain nervous for most of the day about the same issues that have plagued the market all week, including the ongoing tensions between Russia and Ukraine and signs of a further slowdown in the Chinese economy. By...
Why Has David Einhorn Been Selling Rite Aid?
Selena Maranjian, The Motley Fool - Motley Fool - Wed Mar 12, 3:45PM CDT
The latest 13F season is here, when many money managers issue required reports on their holdings. It can be worthwhile to pay attention, as you might get an investment idea or two by seeing what some major investors have been buying and selling. ...
Next Resistance Level for Walgreen (WAG) is $67.59
Comtex SmarTrend(R) - Wed Mar 12, 10:15AM CDT
Walgreen (NYSE:WAG) has opened bullishly above the pivot of $66.66 today and has reached the first level of resistance at $67.06. Analysts will be watching for a cross of the next upside pivot targets of $67.59 and $68.52.
Is Rite Aid a Screaming Buy After Reporting Sales Figures?
Daniel Jones, The Motley Fool - Motley Fool - Wed Mar 12, 8:35AM CDT
Source: Wikimedia Commons After reporting sales for the month of February, Rite Aid , the world's third-largest publicly traded drugstore chain, saw its shares fall more than 1%. Although the company's performance for the month wasn't bad, it...
Will This Target Price Increase Help Walgreen (WAG) Today? (Update)
at The Street - Wed Mar 12, 8:24AM CDT
UBS increased its target price on Walgreen (WAG) to $90 and set a "buy" rating. The firm cited the company's specialty pharma tax inversion playbook to pharma services as the reason for the move.
Infinity Appoints Two Experienced Life Science Leaders to Its Board of Directors
Business Wire - Tue Mar 11, 3:07PM CDT
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that it has appointed Jose Baselga M.D., Ph.D. and Jeff Berkowitz as independent members of its board of directors. Dr. Baselga, physician-in-chief at Memorial Sloan Kettering Cancer Center, is an accomplished clinician and a thought leader in the PI3K field. Mr. Berkowitz, as the President of Walgreens Boots Alliance Development, GmbH (WAG) in Europe, has a wealth of experience in pharmaceuticals, pharmacy, distribution and market access, pricing and reimbursement.
Is Drugstore Titan CVS Caremark Still a Good Bet After Taking a Hard Stance Against Tobacco?
Robert Hanley, The Motley Fool - Motley Fool - Tue Mar 11, 1:17PM CDT
Drugstore giant CVS Caremark made waves in early February after disclosing its intention to forgo tobacco sales starting in October. While some pundits questioned CVS' motives, the policy makes sense for a company that generates the vast majority...
Is Rite Aid Corporation Getting Sick Again?
Adam Levine-Weinberg, The Motley Fool - Motley Fool - Tue Mar 11, 12:10PM CDT
In its recently ended 2014 fiscal year, Rite Aid Corporation made significant progress in returning to sustainable profitability. Through the first three quarters of the fiscal year, the company swung from a pre-tax loss of $69 million in FY13 to...
After Strong Sales Results, Is Walgreen a Strong Buy?
Daniel Jones, The Motley Fool - Motley Fool - Sun Mar 09, 9:00AM CDT
Source: Wikimedia Commons On March 5, shares of Walgreen ended the day down nearly 1% as the S&P 500 index stayed roughly even. The reason for the stock's drop was the sales release the business made public covering the month of February...
Rite Aid Feb Comps Rise - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 07, 1:20PM CST
Rite Aid's comparable store sales for the five weeks ended Mar 1, 2014 increased 1.5%
Harsh Winter Weather Cools February Retail Comps
at Investor's Business Daily - Thu Mar 06, 4:23PM CST
Retailers rang up sluggish sales gains in February as a harsh winter blast in many parts of America kept mall traffic weak and spending soft, though business rallied some in the second half of the month. February sales at stores open at least a year...
Feb Sales Up at Walgreen but Q2 Revs Miss Est. - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 1:50PM CST
Drug retailer Walgreens recently reported results for the month of Feb 2014.
Feb. Retail Comps Stay Chilled But Stage Late Rally
at Investor's Business Daily - Thu Mar 06, 12:06PM CST
Retailers posted soft February sales gains Thursday as frigid temperatures in many parts of the U.S. kept consumers out of the malls, but business picked up during the month's second half -- an encouraging sign given the harsh-weather head winds....
Rite Aid Corporation February Same-Store Sales Up 1.5%
Patrick Morris, The Motley Fool - Motley Fool - Thu Mar 06, 11:39AM CST
Rite Aid announced today that same-store sales last month overall were up 1.5%. Front-end same-store sales decreased 1.8% while pharmacy same-store sales rose 3.1%. Total sales rose from $2.46 billion in the comparable period last year to...
Walgreens and MyMedicalRecords Reach Settlement Agreement
Marketwire - Thu Mar 06, 7:15AM CST
MMRGlobal, Inc. (OTCQB: MMRF), through its wholly owned subsidiary MyMedicalRecords, Inc. (collectively, "MMR"), and Walgreen Co. (NYSE: WAG) (NASDAQ: WAG) ("Walgreens") announced today that they have entered into a Settlement and Licensing Agreement (the "Agreement") to resolve two patent infringement lawsuits brought by MMR. Pursuant to the terms of the Agreement, Walgreens purchased a Non-Exclusive License to the MMR family of patents. The settlement arises from litigation involving MMR's U.S. Patent No. 8,301,466 and U.S. Patent No. 8,498,883. MMR's patent portfolio also includes U.S. Patent Nos. 8,121,855; 8,117,045; 8,117,646; 8,301,466; 8,321,240; 8,352,287; 8,352,288; 8,498,883; 8,626,532 and 8,645,161 as well as numerous pending applications. Pursuant to the terms of the Agreement, Walgreens has also agreed to sell MMR's MyMedicalRecords Personal Health Record (the "MMR-PHR") on drugstore.com. The remaining terms of the Agreement are confidential.
Walgreen reports 5% rise in February sales
M2 - Thu Mar 06, 6:45AM CST
Drug store Walgreen (NYSE:WAG) stated on Wednesday that it recorded sales of USD6.05bin in February fiscal 2014.
